section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Availability

Route/Dosage

One unit/kg increases circulating Factor IX (FIX) level by 1%.

US Brand Names

Alprolix

Action

  • Replaces deficient Factor IX in patients with Hemophilia B.
Therapeutic effects:
  • Decreased incidence and severity of bleeding .

Classifications

Therapeutic Classification: hemostatic agents

Pharmacologic Classification: clotting factors replacements

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Used up in clotting process.

Half-Life: Adults: 86.5 hr; children 12–17 yr: 84 hr; children 6–11 yr: 72.2 hr; children 2–5 yr: 66.4 hr.

Time/Action Profile

(decreased bleeding/risk of bleeding)

ROUTEONSETPEAKDURATION
IVrapidunknown6–48 hr

Up to 10 days when used prophylactically.



Patient/Family Teaching

Pronunciation

ko-A-gyoo-LAY-shun FAC-tor nine eff-cee FYOO-zhun PROH-teen